tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kalpit Patel, 106 are a BUY (82.17%), 21 are a HOLD (16.28%), 2 are a SELL (1.55%).
Analyst Kalpit Patel, currently employed at B. RILEY, carries an average stock price target met ratio of 36.41% that have a potential upside of 30.7% achieved within 133 days. Previously, Kalpit Patel worked at CREDIT SUISSE, 2924.0, B. RILEY, WOLFE.
Kalpit Patel’s has documented 241 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AVBP, ArriVent BioPharma at 20-Oct-2026.
Analyst best performing recommendations are on VSTM (VERASTEM).
The best stock recommendation documented was for VSTM (VERASTEM) at 12/30/2024. The price target of $7 was fulfilled within 4 days with a profit of $3.33 (90.74%) receiving and performance score of 226.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Mar-2022
$14
$10.45 (294.37%)
$15
2 months 27 days ago
(30-Jul-2026)
0/25 (0%)
$9.99 (249.13%)
Buy Since 20-Apr-2021
$8
$4.45 (125.35%)
$8
4 months 24 days ago
(03-Jun-2026)
1/17 (5.88%)
$3.8 (90.48%)
174
Hold Since 15-Feb-2022
$12
$7.9 (192.68%)
6 months 19 days ago
(08-Apr-2026)
0/8 (0%)
$7.02 (140.96%)
Buy Since 12-Jun-2020
$36
$31.9 (778.05%)
7 months 9 days ago
(18-Mar-2026)
3/11 (27.27%)
$31.3 (665.96%)
192
Hold Since 18-Mar-2026
$7
$2.9 (70.73%)
7 months 9 days ago
(18-Mar-2026)
0/3 (0%)
$2.3 (48.94%)
Which stock is Kalpit Patel most bullish on?
Which stock is Kalpit Patel most reserved on?
What Year was the first public recommendation made by Kalpit Patel?
